# Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor
> **Food and Drug Administration** · Final rule; technical amendment. · Published 2014-03-25 · Effective 2014-03-25 · 79 FR 16180
## Document
- **Document number:** 2014-06131
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 79 FR 16180
- **CFR reference:** 21 CFR 522
- **Publication date:** 2014-03-25
- **Effective date:** 2014-03-25
- **HHS docket:** Docket No. FDA-2014-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 104 approved new animal drug applications (NADAs) and 5 approved abbreviated new animal drug applications (ANADAs) for implantation or injectable dosage form new animal drug products from Pfizer, Inc., including its several subsidiaries and divisions, to Zoetis, Inc. FDA is also amending the animal drug regulations to remove entries describing conditions of use for new animal drug products for which no NADA is approved, to make minor corrections, and to reflect a current format. This is being done to increase the accuracy and readability of the regulations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2014/03/25/2014-06131/implantation-or-injectable-dosage-form-new-animal-drugs-change-of-sponsor)
---
*AI Analytics · CC0 1.0*